Recent Company News

• 10:35 AM ET Apr 25, 2025
  

  EU's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for Adcetris (¥4275.0000, 0)

• 10:29 AM ET Apr 25, 2025
  

  EMA CHMP publishes summary of opinions for April meeting

• 02:35 AM ET Apr 22, 2025
  

  Takeda Pharmaceutical completes up-to-¥100.00B buyback (¥4300.0000, 0)

• 08:00 AM ET Apr 21, 2025
  

  Ascentage Pharma announces two of its proprietary novel drugs have been included in the 2025 CSCO Guidelines (HK$37.15, 0.00)

• 10:02 PM ET Apr 08, 2025
  

  Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News

• 07:04 AM ET Apr 08, 2025
  

  BioInvent International receives $1M milestone payment as Takeda moves mezagitamab into phase 3 (SEK 27.15, +2.15)

• 10:11 AM ET Apr 03, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (624 total)

• 08:55 AM ET Apr 02, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:48 AM ET Apr 02, 2025
  

  Takeda Pharmaceutical upgraded to overweight from equal-weight at Morgan Stanley (¥4458.0000, 0)

• 07:36 AM ET Mar 28, 2025
  

  EU's CHMP finalizes review of Mysimba: concludes benefits of Mysimba continue to outweigh its risks